| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | PDZ domain binding | 1.62e-04 | 123 | 83 | 5 | GO:0030165 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | GTPBP4 LONP1 KIF9 ABCA2 ABCA5 SMARCA4 GNAT1 MTREX MORC2 DNAH8 MMUT | 3.54e-04 | 775 | 83 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 4.93e-04 | 441 | 83 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | GTPBP4 LONP1 KIF9 ABCA2 ABCA5 SMARCA4 GNAT1 MTREX MORC2 DNAH8 MMUT | 6.88e-04 | 839 | 83 | 11 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | GTPBP4 LONP1 KIF9 ABCA2 ABCA5 SMARCA4 GNAT1 MTREX MORC2 DNAH8 MMUT | 6.95e-04 | 840 | 83 | 11 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | GTPBP4 LONP1 KIF9 ABCA2 ABCA5 SMARCA4 GNAT1 MTREX MORC2 DNAH8 MMUT | 6.95e-04 | 840 | 83 | 11 | GO:0016818 |
| GeneOntologyMolecularFunction | beta-2 adrenergic receptor binding | 7.52e-04 | 10 | 83 | 2 | GO:0031698 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 9.16e-04 | 11 | 83 | 2 | GO:0098919 | |
| GeneOntologyBiologicalProcess | neuron development | CACNA1A ABLIM1 ERBB2 AHI1 TENM3 TNN LRP1 CDH23 NUMB DLG4 GRID2 GNAT1 SCLT1 CHN1 TENM2 MUSK PREX2 PTK2 | 1.15e-05 | 1463 | 81 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of polarized epithelial cell differentiation | 1.52e-05 | 2 | 81 | 2 | GO:0030862 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | CACNA1A AHI1 TENM3 TNN LRP1 NUMB DLG4 GRID2 FNBP1L CHN1 TENM2 MUSK PTK2 | 2.41e-05 | 846 | 81 | 13 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 2.65e-05 | 612 | 81 | 11 | GO:0010975 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 2.89e-05 | 309 | 81 | 8 | GO:1901888 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | CACNA1A AHI1 TENM3 TNN LRP1 NUMB DLG4 GRID2 FNBP1L CHN1 TENM2 MUSK PTK2 | 2.96e-05 | 863 | 81 | 13 | GO:0031344 |
| GeneOntologyBiologicalProcess | neuron projection development | CACNA1A ABLIM1 ERBB2 AHI1 TENM3 TNN LRP1 CDH23 NUMB DLG4 GRID2 CHN1 TENM2 MUSK PREX2 PTK2 | 3.36e-05 | 1285 | 81 | 16 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CACNA1A ABLIM1 ERBB2 TNN LRP1 CDH23 NUMB DLG4 CHN1 TENM2 PREX2 PTK2 | 3.37e-05 | 748 | 81 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of polarized epithelial cell differentiation | 4.56e-05 | 3 | 81 | 2 | GO:0030860 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | KIF9 ABCA2 LRP1 EPB41L5 NUMB DLG4 GRID2 FNBP1L MORC2 ADGRL2 SCIN TENM2 MUSK PTK2 HCLS1 | 5.30e-05 | 1189 | 81 | 15 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | VPS13D AHI1 TENM3 TNN LRP1 EPB41L5 NUMB DLG4 GRID2 FNBP1L MORC2 ADGRL2 SCIN TENM2 MUSK PTK2 | 6.98e-05 | 1366 | 81 | 16 | GO:0051130 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | PRMT6 PRKD2 ERBB2 LONP1 TBK1 DLG4 PNCK AGBL1 METAP2 BDKRB2 MUSK PTK2 HCLS1 | 1.04e-04 | 976 | 81 | 13 | GO:0018193 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 1.36e-04 | 494 | 81 | 9 | GO:0031346 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.44e-04 | 202 | 81 | 6 | GO:0051963 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 1.61e-04 | 130 | 81 | 5 | GO:1905477 | |
| GeneOntologyBiologicalProcess | positive regulation of cell junction assembly | 1.98e-04 | 136 | 81 | 5 | GO:1901890 | |
| GeneOntologyBiologicalProcess | synapse assembly | 2.09e-04 | 308 | 81 | 7 | GO:0007416 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CACNA1A ABLIM1 ERBB2 TNN LRP1 SMARCA4 EPB41L5 CDH23 NUMB DLG4 CHN1 TENM2 PREX2 PTK2 | 2.10e-04 | 1194 | 81 | 14 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CACNA1A ABLIM1 ERBB2 TNN LRP1 NUMB DLG4 CHN1 TENM2 PREX2 PTK2 | 2.90e-04 | 802 | 81 | 11 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | 3.42e-04 | 237 | 81 | 6 | GO:1905475 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CACNA1A ABLIM1 ERBB2 TNN LRP1 NUMB DLG4 CHN1 TENM2 PREX2 PTK2 | 3.47e-04 | 819 | 81 | 11 | GO:0120039 |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 3.61e-04 | 337 | 81 | 7 | GO:0006898 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse assembly | 3.67e-04 | 86 | 81 | 4 | GO:0051965 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CACNA1A ABLIM1 ERBB2 TNN LRP1 NUMB DLG4 CHN1 TENM2 PREX2 PTK2 | 3.73e-04 | 826 | 81 | 11 | GO:0048858 |
| GeneOntologyBiologicalProcess | axonogenesis | 3.73e-04 | 566 | 81 | 9 | GO:0007409 | |
| GeneOntologyBiologicalProcess | regulation of receptor-mediated endocytosis | 3.74e-04 | 156 | 81 | 5 | GO:0048259 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 3.88e-04 | 569 | 81 | 9 | GO:0034329 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 4.71e-04 | 164 | 81 | 5 | GO:0099072 | |
| GeneOntologyBiologicalProcess | regulation of receptor internalization | 5.36e-04 | 95 | 81 | 4 | GO:0002090 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 1.65e-05 | 78 | 85 | 5 | GO:0001917 | |
| GeneOntologyCellularComponent | synaptic membrane | MPP2 CACNA1A ERBB2 TENM3 LRP1 DLG4 GRID2 ADGRL2 ENO2 TENM2 MUSK | 2.38e-05 | 583 | 85 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.95e-05 | 405 | 85 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | postsynapse | MPP2 CACNA1A ABLIM1 ERBB2 LRP1 NUMB DLG4 GRID2 ADGRL2 TENM2 AP3D1 MUSK PTK2 | 2.28e-04 | 1018 | 85 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | dendritic spine | 4.61e-04 | 242 | 85 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MPP2 CACNA1A TENM3 LRP1 NUMB DLG4 GRID2 ADGRL2 TENM2 AP3D1 PTK2 | 4.64e-04 | 817 | 85 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | neuron spine | 5.14e-04 | 247 | 85 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | cell cortex | 7.89e-04 | 371 | 85 | 7 | GO:0005938 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 9.83e-04 | 48 | 85 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.05e-03 | 12 | 85 | 2 | GO:0036157 | |
| MousePheno | abnormal innervation | 8.74e-06 | 193 | 75 | 8 | MP:0002184 | |
| Domain | Rhs_assc_core | 5.70e-05 | 3 | 82 | 2 | IPR022385 | |
| Domain | Tox-GHH_dom | 1.14e-04 | 4 | 82 | 2 | IPR028916 | |
| Domain | Ten_N | 1.14e-04 | 4 | 82 | 2 | IPR009471 | |
| Domain | Ten_N | 1.14e-04 | 4 | 82 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.14e-04 | 4 | 82 | 2 | PS51361 | |
| Domain | Tox-GHH | 1.14e-04 | 4 | 82 | 2 | PF15636 | |
| Domain | YD | 1.89e-04 | 5 | 82 | 2 | IPR006530 | |
| Domain | - | 6.65e-04 | 39 | 82 | 3 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.08e-03 | 46 | 82 | 3 | IPR011042 | |
| Domain | P-loop_NTPase | MPP2 GTPBP4 LONP1 KIF9 ABCA2 ABCA5 SMARCA4 DLG4 GNAT1 MTREX DNAH8 | 1.17e-03 | 848 | 82 | 11 | IPR027417 |
| Domain | ABC_A | 1.22e-03 | 12 | 82 | 2 | IPR026082 | |
| Domain | Protein_kinase_ATP_BS | 1.38e-03 | 379 | 82 | 7 | IPR017441 | |
| Domain | NHL | 1.44e-03 | 13 | 82 | 2 | PS51125 | |
| Domain | - | MPP2 GTPBP4 LONP1 ABCA2 ABCA5 SMARCA4 DLG4 GNAT1 MTREX DNAH8 | 1.55e-03 | 746 | 82 | 10 | 3.40.50.300 |
| Domain | Guanylate_kinase_CS | 2.20e-03 | 16 | 82 | 2 | IPR020590 | |
| Domain | EGF_extracell | 2.33e-03 | 60 | 82 | 3 | IPR013111 | |
| Domain | EGF_2 | 2.33e-03 | 60 | 82 | 3 | PF07974 | |
| Domain | CarboxyPept-like_regulatory | 2.48e-03 | 17 | 82 | 2 | IPR008969 | |
| Domain | SH3 | 2.62e-03 | 216 | 82 | 5 | SM00326 | |
| Domain | SH3 | 2.62e-03 | 216 | 82 | 5 | PS50002 | |
| Domain | SH3_domain | 2.83e-03 | 220 | 82 | 5 | IPR001452 | |
| Domain | PDZ | 3.45e-03 | 141 | 82 | 4 | PF00595 | |
| Domain | AAA+_ATPase | 3.72e-03 | 144 | 82 | 4 | IPR003593 | |
| Domain | AAA | 3.72e-03 | 144 | 82 | 4 | SM00382 | |
| Domain | EGF_3 | 3.76e-03 | 235 | 82 | 5 | PS50026 | |
| Domain | EGF | 3.76e-03 | 235 | 82 | 5 | SM00181 | |
| Domain | DAG/PE-bd | 3.79e-03 | 21 | 82 | 2 | IPR020454 | |
| Domain | PROTEIN_KINASE_ATP | 4.03e-03 | 459 | 82 | 7 | PS00107 | |
| Domain | PDZ | 4.10e-03 | 148 | 82 | 4 | SM00228 | |
| Domain | - | 4.30e-03 | 150 | 82 | 4 | 2.30.42.10 | |
| Domain | PDZ | 4.41e-03 | 151 | 82 | 4 | PS50106 | |
| Domain | PDZ | 4.51e-03 | 152 | 82 | 4 | IPR001478 | |
| Domain | GUANYLATE_KINASE_2 | 4.54e-03 | 23 | 82 | 2 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 4.54e-03 | 23 | 82 | 2 | PS00856 | |
| Domain | EGF-like_dom | 4.80e-03 | 249 | 82 | 5 | IPR000742 | |
| Domain | EGF_1 | 5.30e-03 | 255 | 82 | 5 | PS00022 | |
| Domain | Prot_kinase_dom | 5.67e-03 | 489 | 82 | 7 | IPR000719 | |
| Domain | Guanylate_kin | 5.78e-03 | 26 | 82 | 2 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 5.78e-03 | 26 | 82 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 5.78e-03 | 26 | 82 | 2 | IPR008144 | |
| Domain | GuKc | 5.78e-03 | 26 | 82 | 2 | SM00072 | |
| Domain | EGF-like_CS | 5.84e-03 | 261 | 82 | 5 | IPR013032 | |
| Pubmed | MPP2 CACNA1A CDK17 HDAC11 DPP6 ABLIM1 LONP1 EIF3L SMARCA4 KIAA1549 DLG4 CDC5L NT5DC3 ENO2 METAP2 AP3D1 | 3.35e-07 | 1431 | 85 | 16 | 37142655 | |
| Pubmed | 1.67e-06 | 10 | 85 | 3 | 38713721 | ||
| Pubmed | GTPBP4 PRKD2 CHAF1B ERBB2 TBK1 RALYL LRP1 SMARCA4 KIAA1549 DLG4 TNFRSF10B ADGRL2 AGBL1 | 3.10e-06 | 1116 | 85 | 13 | 31753913 | |
| Pubmed | MPP2 ZNF462 CACNA1A GTPBP4 ABLIM1 TBK1 LRP1 SMARCA4 DLG4 CDC5L TENM2 PTK2 | 3.90e-06 | 963 | 85 | 12 | 28671696 | |
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 33305180 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 27286256 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21628556 | ||
| Pubmed | Spinocerebellar ataxia type 12 was not found in Korean Parkinsonian patients. | 5.90e-06 | 2 | 85 | 2 | 18973067 | |
| Pubmed | The role of retinol dehydrogenase 10 in the cone visual cycle. | 5.90e-06 | 2 | 85 | 2 | 28539612 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18279360 | ||
| Pubmed | 1.12e-05 | 18 | 85 | 3 | 19455133 | ||
| Pubmed | A quantitative survey of gravity receptor function in mutant mouse strains. | 1.56e-05 | 20 | 85 | 3 | 16235133 | |
| Pubmed | EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy. | 1.77e-05 | 3 | 85 | 2 | 33208750 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 24217252 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 16275754 | ||
| Pubmed | Erbin is a protein concentrated at postsynaptic membranes that interacts with PSD-95. | 1.77e-05 | 3 | 85 | 2 | 11279080 | |
| Pubmed | Ethanol enhances the interaction of breast cancer cells over-expressing ErbB2 with fibronectin. | 1.77e-05 | 3 | 85 | 2 | 20201928 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 28459212 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 11807823 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 19756182 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 18832579 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 27464303 | ||
| Pubmed | Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. | 1.77e-05 | 3 | 85 | 2 | 10839362 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 29166599 | ||
| Pubmed | 1.77e-05 | 63 | 85 | 4 | 17672918 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | GTPBP4 PRKD2 ABLIM1 TBK1 EIF3L SMARCA4 EPB41L5 NUMB NUP93 CDC5L AP3D1 | 2.00e-05 | 949 | 85 | 11 | 36574265 |
| Pubmed | 2.44e-05 | 234 | 85 | 6 | 36243803 | ||
| Pubmed | 2.65e-05 | 638 | 85 | 9 | 33239621 | ||
| Pubmed | 2.85e-05 | 493 | 85 | 8 | 15368895 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 22279216 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 3.53e-05 | 4 | 85 | 2 | 10225957 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 8910533 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 37531828 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 23592719 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 21483099 | ||
| Pubmed | Neuregulin-1 enhances motility and migration of human astrocytic glioma cells. | 3.53e-05 | 4 | 85 | 2 | 12600989 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 25391374 | ||
| Pubmed | PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies. | 3.53e-05 | 4 | 85 | 2 | 31690171 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 20558745 | ||
| Pubmed | Reciprocal repulsions instruct the precise assembly of parallel hippocampal networks. | 3.53e-05 | 4 | 85 | 2 | 34083484 | |
| Pubmed | Dependence of parvalbumin expression on Purkinje cell input in the deep cerebellar nuclei. | 3.53e-05 | 4 | 85 | 2 | 9514513 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 3.53e-05 | 4 | 85 | 2 | 12000766 | |
| Pubmed | RTK/ERK pathway under natural selection associated with prostate cancer. | 3.53e-05 | 4 | 85 | 2 | 24223781 | |
| Pubmed | PRMT6 GTPBP4 CHAF1B LONP1 EIF3L SMARCA4 NUP93 PSME2 CDC5L MTREX MORC2 | 3.65e-05 | 1014 | 85 | 11 | 32416067 | |
| Pubmed | 4.42e-05 | 28 | 85 | 3 | 18067320 | ||
| Pubmed | GTPBP4 ABLIM1 CHAF1B LONP1 AASS EIF3L UMPS NUP93 PSME2 CDC5L MTREX ADGRL2 AP3D1 | 4.58e-05 | 1440 | 85 | 13 | 30833792 | |
| Pubmed | 4.69e-05 | 263 | 85 | 6 | 34702444 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK17 ABLIM1 ERBB2 VPS13D AASS EPB41L5 NUMB NUP93 MTREX MUSK | 4.81e-05 | 861 | 85 | 10 | 36931259 |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 24256316 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 27519953 | ||
| Pubmed | Cyanidin-3-glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2. | 5.87e-05 | 5 | 85 | 2 | 21034468 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF462 DPP6 ABLIM1 GALNT10 ERBB2 TBK1 RDH10 TMEM63B LRP1 NUMB FNBP1L ZMAT1 PTK2 | 6.44e-05 | 1489 | 85 | 13 | 28611215 |
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 7.23e-05 | 90 | 85 | 4 | 16273093 | |
| Pubmed | 7.88e-05 | 92 | 85 | 4 | 20301317 | ||
| Pubmed | 7.94e-05 | 421 | 85 | 7 | 36976175 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 22328506 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 10446746 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 20463225 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.13e-04 | 101 | 85 | 4 | 23382219 | |
| Pubmed | 1.14e-04 | 446 | 85 | 7 | 24255178 | ||
| Pubmed | Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. | 1.23e-04 | 7 | 85 | 2 | 16767099 | |
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 19036954 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 23760271 | ||
| Pubmed | Cochlear histopathology of the mutant bustling mouse, BUS/Idr. | 1.23e-04 | 7 | 85 | 2 | 8790740 | |
| Pubmed | miR-129-3p controls cilia assembly by regulating CP110 and actin dynamics. | 1.23e-04 | 7 | 85 | 2 | 22684256 | |
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 10625539 | ||
| Pubmed | Direct interaction of GluRdelta2 with Shank scaffold proteins in cerebellar Purkinje cells. | 1.23e-04 | 7 | 85 | 2 | 15207857 | |
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 12915301 | ||
| Pubmed | GTPBP4 TBK1 RDH10 SMARCA4 EPB41L5 NUMB UMPS NUP93 MTREX MORC2 METAP2 AP3D1 | 1.24e-04 | 1371 | 85 | 12 | 36244648 | |
| Pubmed | 1.45e-04 | 323 | 85 | 6 | 24797263 | ||
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 1.57e-04 | 110 | 85 | 4 | 37219487 | |
| Pubmed | Behavioral effects of neonatal lesions on the cerebellar system. | 1.64e-04 | 8 | 85 | 2 | 25907855 | |
| Pubmed | Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. | 1.64e-04 | 8 | 85 | 2 | 10655525 | |
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 10331952 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 17360663 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 19563800 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.67e-04 | 475 | 85 | 7 | 31040226 | |
| Pubmed | 1.89e-04 | 215 | 85 | 5 | 30462309 | ||
| Pubmed | 1.98e-04 | 46 | 85 | 3 | 34815492 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GTPBP4 ABLIM1 CHAF1B LONP1 TBK1 SMARCA4 NUP93 CDC5L MTREX SCIN | 1.99e-04 | 1024 | 85 | 10 | 24711643 |
| Pubmed | 2.06e-04 | 118 | 85 | 4 | 21078624 | ||
| Pubmed | 2.10e-04 | 9 | 85 | 2 | 23986861 | ||
| Pubmed | The long noncoding RNA Synage regulates synapse stability and neuronal function in the cerebellum. | 2.10e-04 | 9 | 85 | 2 | 33762741 | |
| Pubmed | 2.10e-04 | 9 | 85 | 2 | 17938206 | ||
| Pubmed | 2.13e-04 | 347 | 85 | 6 | 17114649 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CDK17 PRKD2 ABLIM1 TBK1 EIF3L NUMB SNAPC3 MTREX METAP2 AP3D1 | 2.22e-04 | 1038 | 85 | 10 | 26673895 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 2.26e-04 | 665 | 85 | 8 | 30457570 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.27e-04 | 351 | 85 | 6 | 38297188 | |
| Pubmed | 2.33e-04 | 225 | 85 | 5 | 31478661 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.52e-04 | 358 | 85 | 6 | 32460013 | |
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 19298847 | ||
| Pubmed | The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based study. | 2.62e-04 | 10 | 85 | 2 | 19259763 | |
| Pubmed | Screening for premutation in the FMR1 gene in male patients suspected of spinocerebellar ataxia. | 2.62e-04 | 10 | 85 | 2 | 19235102 | |
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 20592197 | ||
| Pubmed | 2.79e-04 | 686 | 85 | 8 | 28380382 | ||
| Pubmed | Ephrin-A5 and EphA5 interaction induces synaptogenesis during early hippocampal development. | 3.20e-04 | 11 | 85 | 2 | 20824214 | |
| Pubmed | 3.21e-04 | 529 | 85 | 7 | 14621295 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 3.22e-04 | 701 | 85 | 8 | 30196744 | |
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 11700294 | ||
| Pubmed | 3.86e-04 | 251 | 85 | 5 | 27507650 | ||
| Cytoband | 3q13 | 1.84e-04 | 11 | 85 | 2 | 3q13 | |
| GeneFamily | ATP binding cassette subfamily A | 8.37e-04 | 14 | 56 | 2 | 805 | |
| GeneFamily | PDZ domain containing | 1.26e-03 | 152 | 56 | 4 | 1220 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 2.92e-03 | 26 | 56 | 2 | 904 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ZNF462 CACNA1A DPP6 PPP2R2B RALYL KIAA1549 GRID2 PNCK FNBP1L CHN1 SCIN NT5DC3 TENM2 ZMAT1 PDZD4 | 2.45e-06 | 1106 | 85 | 15 | M39071 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | CDK17 AHI1 ACACB TBK1 LRP1 SMARCA4 NUMB PSME2 MORC2 NT5DC3 PTK2 HCLS1 | 9.06e-06 | 790 | 85 | 12 | M12490 |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.33e-05 | 240 | 85 | 7 | M39236 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 2.46e-05 | 600 | 85 | 10 | M39055 | |
| Coexpression | GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP | 4.85e-05 | 200 | 85 | 6 | M9771 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_42_PRECICTIVE_ICB_RESISTANCE | 5.42e-05 | 204 | 85 | 6 | MM17085 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 179 | 85 | 6 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.49e-06 | 185 | 85 | 6 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.74e-06 | 190 | 85 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-06 | 192 | 85 | 6 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-06 | 199 | 85 | 6 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 154 | 85 | 5 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 159 | 85 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 166 | 85 | 5 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.92e-05 | 171 | 85 | 5 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 172 | 85 | 5 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 172 | 85 | 5 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 172 | 85 | 5 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 179 | 85 | 5 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.39e-05 | 179 | 85 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.66e-05 | 183 | 85 | 5 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.80e-05 | 185 | 85 | 5 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.87e-05 | 186 | 85 | 5 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.87e-05 | 186 | 85 | 5 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.95e-05 | 187 | 85 | 5 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.02e-05 | 188 | 85 | 5 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.02e-05 | 188 | 85 | 5 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 189 | 85 | 5 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.10e-05 | 189 | 85 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 189 | 85 | 5 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.18e-05 | 190 | 85 | 5 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 3.18e-05 | 190 | 85 | 5 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.26e-05 | 191 | 85 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.26e-05 | 191 | 85 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 3.34e-05 | 192 | 85 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-05 | 192 | 85 | 5 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.42e-05 | 193 | 85 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.42e-05 | 193 | 85 | 5 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 194 | 85 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.51e-05 | 194 | 85 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 3.60e-05 | 195 | 85 | 5 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 196 | 85 | 5 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.69e-05 | 196 | 85 | 5 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 196 | 85 | 5 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 196 | 85 | 5 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.78e-05 | 197 | 85 | 5 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.78e-05 | 197 | 85 | 5 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.87e-05 | 198 | 85 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.87e-05 | 198 | 85 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.87e-05 | 198 | 85 | 5 | 3c3a5d2555f6af4aa33f9ea778808315d0e39d86 | |
| ToppCell | facs-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.96e-05 | 199 | 85 | 5 | c11e0044d3cc37f6bb26df033ad4448b419addfc | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.96e-05 | 199 | 85 | 5 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-05 | 199 | 85 | 5 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-05 | 200 | 85 | 5 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.06e-05 | 200 | 85 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.06e-05 | 200 | 85 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.06e-05 | 200 | 85 | 5 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.06e-05 | 200 | 85 | 5 | e4f0bb57be1112869c7068d0a789c2b802a442dd | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 139 | 85 | 4 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-04 | 145 | 85 | 4 | c0894c738815ff54790caddb4bccfa1503fd555b | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 1.85e-04 | 148 | 85 | 4 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-04 | 148 | 85 | 4 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.95e-04 | 150 | 85 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 155 | 85 | 4 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-maDC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-04 | 156 | 85 | 4 | 095281ea78aefa0ee638191a03f8d6f62a86a9ff | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.26e-04 | 156 | 85 | 4 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-04 | 156 | 85 | 4 | 29b04143f71a0ecc600ac670abd1d521bee55fe7 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 157 | 85 | 4 | cbb08d5c151f0622123276926a2a15bb7d271e90 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 157 | 85 | 4 | 16581e2399a211633f870dce326c75ff4b6a5fe6 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 158 | 85 | 4 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 159 | 85 | 4 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 159 | 85 | 4 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.43e-04 | 159 | 85 | 4 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 159 | 85 | 4 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 160 | 85 | 4 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-04 | 160 | 85 | 4 | 5c931e859acf67c1c8664941e0e44d195f8ba75b | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 160 | 85 | 4 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.55e-04 | 161 | 85 | 4 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 161 | 85 | 4 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | Int-URO-Myeloid-cDC1|Int-URO / Disease, Lineage and Cell Type | 2.74e-04 | 164 | 85 | 4 | f4628a7ff0dc765a5337ab499b3d61fc25573a16 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 164 | 85 | 4 | 18eeda51e69722992c3a7f699be293535a90868b | |
| ToppCell | BAL-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 2.74e-04 | 164 | 85 | 4 | 4bd9629d054545d1e3f9e5c127b5ac2388637106 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.87e-04 | 166 | 85 | 4 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.87e-04 | 166 | 85 | 4 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 167 | 85 | 4 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 167 | 85 | 4 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-Progen-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.93e-04 | 167 | 85 | 4 | b89ebd4906f52b1fe6b6540ec9339284e7caddd2 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 168 | 85 | 4 | 08fe8fa43c343c03f9a2f0b982192fde04a7c027 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 168 | 85 | 4 | d4053b2fffb19e0376b8ceb92e87ec4447d96a3e | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.07e-04 | 169 | 85 | 4 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-04 | 170 | 85 | 4 | a6fa0cab1fa829ec601fe48306b4c43c83425b04 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-04 | 170 | 85 | 4 | b40255eee45eb18b5a297336d7f3845fd8f8aa3b | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.14e-04 | 170 | 85 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 171 | 85 | 4 | 159ce6d5513008532dd7785b915b3fe7440cc4b2 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.21e-04 | 171 | 85 | 4 | 3112d15f2a28cf4a71992db4971d960716dc1264 | |
| ToppCell | NS-critical-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.28e-04 | 172 | 85 | 4 | c0b5e4889aef2f168d9f6db19a63b24bfd249316 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 172 | 85 | 4 | 490745024730df6357f6c2b81d7a64e21557c0d5 | |
| ToppCell | 3'_v3-blood-Mast|blood / Manually curated celltypes from each tissue | 3.28e-04 | 172 | 85 | 4 | e7a46bbeff749ca59b9f1357409ce1ad59dd22dd | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 172 | 85 | 4 | 33c201aaa98acbf1901b6fa6ce0d3ff8012a4d94 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 173 | 85 | 4 | a5b6c3d58f7a8e533330798b81496009a31548af | |
| ToppCell | Bac-SEP-Myeloid-cDC1|Bac-SEP / Disease, Lineage and Cell Type | 3.35e-04 | 173 | 85 | 4 | f88269327441858ddb8c49b9dd619b76fd53b1da | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 173 | 85 | 4 | cc094992b8027f4cef38f0fb0b76f0d07210d1e2 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 174 | 85 | 4 | 7be0c6248e77f2d0260b852b01e17892f7828f1b | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.43e-04 | 174 | 85 | 4 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-04 | 175 | 85 | 4 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 175 | 85 | 4 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| Disease | Spinocerebellar Ataxia Type 2 | 1.25e-04 | 34 | 84 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.25e-04 | 34 | 84 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.25e-04 | 34 | 84 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.25e-04 | 34 | 84 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.25e-04 | 34 | 84 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.25e-04 | 34 | 84 | 3 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.36e-04 | 35 | 84 | 3 | C0752122 | |
| Disease | Cocaine-Related Disorders | 3.55e-04 | 117 | 84 | 4 | C0236736 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 4.20e-04 | 51 | 84 | 3 | EFO_0022285 | |
| Disease | Cocaine Abuse | 4.84e-04 | 127 | 84 | 4 | C0009171 | |
| Disease | brain disease (is_implicated_in) | 5.19e-04 | 12 | 84 | 2 | DOID:936 (is_implicated_in) | |
| Disease | alkaline phosphatase measurement | 6.12e-04 | 1015 | 84 | 10 | EFO_0004533 | |
| Disease | Modic type vertebral endplate changes | 6.12e-04 | 13 | 84 | 2 | HP_0030775 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 6.12e-04 | 13 | 84 | 2 | OBA_2045174 | |
| Disease | S-6-hydroxywarfarin measurement | 6.48e-04 | 368 | 84 | 6 | EFO_0803326 | |
| Disease | Cocaine Dependence | 6.80e-04 | 139 | 84 | 4 | C0600427 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 7.13e-04 | 14 | 84 | 2 | OBA_2045100 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 8.21e-04 | 15 | 84 | 2 | OBA_2045067 | |
| Disease | neuroimaging measurement | 9.10e-04 | 1069 | 84 | 10 | EFO_0004346 | |
| Disease | triiodothyronine measurement | 9.36e-04 | 16 | 84 | 2 | EFO_0008392 | |
| Disease | migraine without aura, susceptibility to, 4 | 9.36e-04 | 16 | 84 | 2 | MONDO_0011847 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 9.58e-04 | 264 | 84 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.04e-03 | 156 | 84 | 4 | C0007131 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 1.33e-03 | 19 | 84 | 2 | EFO_0802076 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 1.47e-03 | 20 | 84 | 2 | OBA_2045071 | |
| Disease | obsolete_red blood cell distribution width | PRMT6 LONP1 AHI1 TMCC2 EIF3L TMEM63B CDH23 DHDDS MIGA1 MUSK PTK2 | 1.50e-03 | 1347 | 84 | 11 | EFO_0005192 |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.76e-03 | 303 | 84 | 5 | EFO_0004612, EFO_0020945 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.92e-03 | 86 | 84 | 3 | EFO_0008595, EFO_0020945 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 1.95e-03 | 23 | 84 | 2 | OBA_2045158 | |
| Disease | creatinine measurement | 2.08e-03 | 995 | 84 | 9 | EFO_0004518 | |
| Disease | lip morphology measurement | 2.11e-03 | 189 | 84 | 4 | EFO_0007845 | |
| Disease | Dysphagia | 2.12e-03 | 24 | 84 | 2 | HP_0002015 | |
| Disease | health study participation | 2.36e-03 | 195 | 84 | 4 | EFO_0010130 | |
| Disease | serum urea measurement | 2.36e-03 | 195 | 84 | 4 | EFO_0009795 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 2.49e-03 | 26 | 84 | 2 | OBA_2045194 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 2.49e-03 | 26 | 84 | 2 | OBA_2045191 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGHRVSEIDEMFEAR | 541 | Q8WWZ7 | |
| EMREMGRDGYSDSEH | 2066 | O00555 | |
| KGMSYLEDVRLVHRD | 831 | P04626 | |
| RTMKEYSDEGHNVTA | 196 | P30411 | |
| DVKFSHSGRYIMTRD | 286 | Q00005 | |
| DPSYVKQMERESREH | 461 | Q99459 | |
| AEGYQDVRDRMIHRS | 436 | O14639 | |
| GVYIHRTDRLKSDFM | 346 | Q8N157 | |
| MDDKDDAHYAVQARR | 531 | Q9BZE4 | |
| NGHERDFMDDKRVYI | 186 | Q96DB2 | |
| YEKMVDHRGVRVVAF | 136 | Q9UDR5 | |
| IGAEGEARSYRMFHD | 216 | Q13112 | |
| RDMEIKGASHHVYAD | 311 | Q8TB40 | |
| MAHREIAYKDGVHEL | 831 | O95490 | |
| RGSKDFSTHEIFRME | 156 | Q9BZ11 | |
| DRHMGVITAAKELDY | 1686 | Q9H251 | |
| ESFRDAMRLGAEVYH | 176 | P09104 | |
| TIGKYSDDHEMRNEV | 181 | Q96DT6 | |
| DRRIHYMISKGGSEA | 41 | Q96MI9 | |
| MTHVDKAEGTTYRDE | 381 | O14617 | |
| ESRKRTFGMAEEYHR | 116 | Q8N1F7 | |
| QYMSERHARAAVAGE | 61 | Q86SE5 | |
| YGEDEAGRREATHML | 1856 | Q9HCM3 | |
| KHIEEGGESRYMITD | 1881 | O00763 | |
| EAAEAHRQVRKYVMS | 171 | P50579 | |
| YGDSARQDDARKLMH | 91 | P11488 | |
| DMIHIADTKVARRYG | 526 | Q9Y262 | |
| HDDFRYETQAGDAMR | 271 | Q86SR1 | |
| RIDAMDVHVKAGRVY | 3901 | Q07954 | |
| TVLDSAVYEHVRMKG | 681 | O43424 | |
| MLAHGARSADGKRVY | 746 | Q76G19 | |
| EHDVLRDDGIMYAKR | 346 | Q6PIU2 | |
| HAKDYDRIMAVISRE | 1621 | Q96JB1 | |
| GKMGERYITHESDDA | 821 | Q9BZL6 | |
| GMTDVAEIKGHRRTY | 551 | P36776 | |
| ALSAMSAEHERADKY | 141 | A0A1B0GV03 | |
| MEADVRAGRYLEHGE | 431 | Q14168 | |
| RVSAEEAMKHVYFRS | 461 | Q00537 | |
| HEMIRYGDDKRSIDI | 21 | Q9HAQ2 | |
| MEGERRAYSKEVHQR | 1 | Q96M63 | |
| ADAKEYRHLLRAMGE | 431 | Q9Y6X9 | |
| RIMERGSYTEKDASH | 101 | Q6P2M8 | |
| GVDMHVVKARDGNDY | 231 | Q9HCM4 | |
| REVVAEEMAHRVYGE | 86 | Q5T0N5 | |
| EAKYHAMISENRRAV | 71 | Q96BQ5 | |
| RDRVEQEYVASAMHG | 86 | Q5T3F8 | |
| VKREYDHMNGSRESP | 66 | Q01543 | |
| YGHDIRTEMDEIRKN | 1051 | Q9BZC7 | |
| VHEEMIADRVRTDAY | 56 | Q96LA8 | |
| DGRDYHFVSSREKME | 576 | P78352 | |
| IVMADERFHGEGYRE | 11 | Q8WV07 | |
| YGREFHGMISREAAD | 46 | P15882 | |
| GLDNRAYEMTKVAHR | 761 | P42658 | |
| HSVLQKARDMYAEER | 251 | Q86SQ9 | |
| VKYLGHVEVDESRGM | 41 | P49757 | |
| EAMHLVEEGKIYSRV | 356 | Q8NAN2 | |
| DEKERSPEMHRVSYA | 121 | O75069 | |
| MDAVAVYHGKISRET | 1 | O60880 | |
| RDRMDKSAVGHEYVA | 91 | P14317 | |
| MARELYHEEFARAGK | 1 | Q9Y6U3 | |
| DVHIKGIMYRAIEAD | 256 | Q86UY8 | |
| DMGVSSVREKYELAH | 101 | Q05397 | |
| RSHGEKQLEDYGMDV | 476 | Q86UD5 | |
| MFGRGSRHRKEVDYS | 1366 | P51532 | |
| THGRIKEVQYEMFRS | 2156 | Q9NT68 | |
| VHERDEAAYGELRAM | 191 | Q9UL46 | |
| HDRGYGKFQTARMED | 281 | Q92966 | |
| TAGMVRHIYRDLEAA | 76 | Q8IZV5 | |
| GEIRVKSMEYVSRHA | 331 | O00327 | |
| VAVGVYARLMKHAEA | 41 | Q86UF1 | |
| GRMNKYRSLRETDHD | 396 | Q70EL2 | |
| FDEIHYMRDSERGVV | 251 | P42285 | |
| RYTSADGDTKEMAVH | 476 | Q9UQP3 | |
| DYTRAAVRMAEEHSE | 381 | P11172 | |
| HVRYGMTLDEEKARI | 2606 | Q9P273 | |
| RTPRKHSDYAAVMEA | 186 | Q70Z35 | |
| GRGNESDYRKLEEMH | 436 | Q96NL6 | |
| AKAEAAGHRDTLYTM | 371 | O14763 | |
| AYAMSGEAQHRDAVE | 306 | Q6PF05 | |
| SKAEDRELMRFSDHG | 2391 | Q96JM2 | |
| MERAGLGEKSTEYAH | 156 | Q96PQ6 | |
| KVHPRYDLDGDASMA | 401 | Q9UHD2 | |
| FRKMRENSVDTHGYR | 326 | Q5H9K5 | |
| FMLHRARDAVSYTDK | 341 | Q5THJ4 | |
| GKTMDNRHQSEREYI | 4121 | Q5THJ4 | |
| LVMEEKTHRGLYRSE | 411 | O15146 | |
| AGMAYLSERKFVHRD | 711 | O15146 | |
| HKANDRMVSGAYRQE | 576 | P22033 |